Perceive Bio

Perceive Bio is a biotechnology startup based in South San Francisco, California. The company operates in the healthcare sector, specifically focusing on the development of novel therapeutics to prevent irreversible blindness. The company's primary focus is on retinal degeneration, a leading cause of blindness.

Perceive Bio's business model is centered around the translation of protective biology into powerful therapies. This involves the application of decades of academic research into two of the strongest protective biologies in retinal degeneration. The company's team, which boasts a successful track record in translating science through clinical development into strategic value, is currently preparing for clinical trials with lead programs in dry Age-Related Macular Degeneration (AMD) neuroprotection.

The company's revenue model is likely based on the development and commercialization of these novel therapeutics. Once the therapies have been clinically approved, they can be sold to healthcare providers and patients. The market for such therapies is significant, given the prevalence of retinal degeneration and the lack of effective treatments currently available.

In summary, Perceive Bio is a promising biotech startup that leverages academic research and clinical development to create innovative therapies for retinal degeneration. The company operates in a large and growing market, and its focus on novel protective biologies could position it well for future success.

Keywords: Biotechnology, Healthcare, Retinal Degeneration, Therapeutics, Clinical Development, AMD Neuroprotection, Protective Biology, Academic Research, Novel Therapies, Commercialization.